Eder Fernando Rios-Bracamontes
Overview
Explore the profile of Eder Fernando Rios-Bracamontes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mendoza-Cano O, Vazquez-Yanez A, Trujillo X, Huerta M, Rios-Silva M, Lugo-Radillo A, et al.
Public Health
. 2024 Nov;
238():53-58.
PMID: 39615245
Objectives: This study aimed to analyze the burden of cardiovascular disease (CVD) attributable to particulate matter (PM) pollution in Latin American and Caribbean (LAC) countries and territories, and its relationship...
2.
Rios-Bracamontes E, Mendoza-Cano O, Lugo-Radillo A, Ortega-Ramirez A, Murillo-Zamora E
Trop Med Infect Dis
. 2024 Sep;
9(9).
PMID: 39330891
This study aimed to identify the factors associated with all-cause in-hospital mortality in laboratory-confirmed dengue cases from 2020 to mid-2024. A nationwide retrospective cohort study was conducted in Mexico and...
3.
Venegas-Ramirez J, Barrios-Mora K, Rios-Bracamontes E, Guzman-Esquivel J, Cardenas-Rojas M, Murillo-Zamora E
J Clin Med
. 2023 Dec;
12(23).
PMID: 38068339
In patients with end-stage kidney disease (ESKD), peritoneal dialysis (PD) is increasingly being adopted in developing nations due to its cost-effectiveness and advantages as a home-based treatment. However, the survival...
4.
Mendoza-Cano O, Trujillo X, Rios-Silva M, Lugo-Radillo A, Benites-Godinez V, Bricio-Barrios J, et al.
Vaccines (Basel)
. 2023 Oct;
11(10).
PMID: 37896916
The global health emergency caused by COVID-19 concluded in May 2023, marking the beginning of an endemic phase. This study aimed to evaluate the association between vaccination status and other...
5.
Benites-Godinez V, Mendoza-Cano O, Trujillo X, Rios-Silva M, Lugo-Radillo A, Bricio-Barrios J, et al.
Diseases
. 2023 Sep;
11(3).
PMID: 37754315
In May 2023, the global health emergency status of COVID-19 concluded, marking the onset of an endemic era. This study assessed survival rates among PCR-confirmed adult inpatients during this phase...
6.
Mendoza-Cano O, Trujillo X, Huerta M, Rios-Silva M, Guzman-Esquivel J, Lugo-Radillo A, et al.
Vaccines (Basel)
. 2023 Aug;
11(8).
PMID: 37631862
The COVID-19 pandemic has had a devastating impact on global health, necessitating urgent and effective strategies to mitigate its consequences. Vaccination programs have been implemented worldwide to combat virus transmission...
7.
Rios-Bracamontes E, Iniguez-Arias L, Ochoa-Jimenez R, Guzman-Esquivel J, Cardenas-Rojas M, Murillo-Zamora E
Vaccines (Basel)
. 2023 Jul;
11(7).
PMID: 37515075
Understanding the risk factors associated with COVID-19 infection among healthcare workers is crucial for infection prevention and control. The aim of this study was to examine the risk of testing...
8.
Mendoza-Cano O, Trujillo X, Huerta M, Rios-Silva M, Lugo-Radillo A, Benites-Godinez V, et al.
Trop Med Infect Dis
. 2023 Jul;
8(7).
PMID: 37505647
Dengue fever remains a significant global health concern, imposing a substantial burden on public health systems worldwide. Recent studies have suggested that climate change, specifically the increase in surface temperatures...
9.
Lugo-Radillo A, Mendoza-Cano O, Trujillo X, Huerta M, Rios-Silva M, Guzman-Esquivel J, et al.
Trop Med Infect Dis
. 2023 Apr;
8(4).
PMID: 37104357
The transmission of the dengue virus in Mexico has historically been high, and its burden during the COVID-19 pandemic is currently not well understood. Our objective was to assess the...
10.
Trujillo X, Mendoza-Cano O, Rios-Silva M, Huerta M, Guzman-Esquivel J, Benites-Godinez V, et al.
Vaccines (Basel)
. 2023 Mar;
11(3).
PMID: 36992210
Background: Repeated SARS-CoV-2 infections are plausible and related published data are scarce. We aimed to identify factors associated with the risk of recurrent (three episodes) laboratory-confirmed symptomatic SARS-CoV-2 infections. Methods:...